• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部皮质类固醇停药:10 例儿童病例系列。

Topical Steroid Withdrawal: A Case Series of 10 Children.

机构信息

Royal Randwick Medical Centre, 70/73-115 Belmore Road, Randwick NSW 203, Australia.

出版信息

Acta Derm Venereol. 2019 May 1;99(6):551-556. doi: 10.2340/00015555-3144.

DOI:10.2340/00015555-3144
PMID:30734047
Abstract

Concerns about topical steroid withdrawal are causing some patients to cease long-term topical corticosteroid therapy, however, little is known about the ensuing clinical outcomes. This qualitative case series studied 10 children whose parents stopped their chronic topical corticosteroid use and subsequently developed features typically reported in adults experiencing topical steroid withdrawal. Patients were seen in an Australian general practice between April 2014 and October 2018, with follow-up periods ranging from 18 months to 4 years. Symptoms were difficult initially for the children and their families, however, all ultimately improved. At the final review, 4 of the children had clear skin and another 4 had symptoms consistent with their original, pre-treatment atopic dermatitis. More research is required into long-term topical corticosteroid use and its discontinuation, including topical steroid withdrawal, particularly in the pediatric population.

摘要

人们对于局部皮质类固醇戒断的担忧导致一些患者停止长期局部皮质类固醇治疗,但对于随之而来的临床结果却知之甚少。本案例系列研究了 10 名儿童,其父母停止了他们的慢性局部皮质类固醇的使用,随后出现了成人中常报道的局部皮质类固醇戒断的特征。2014 年 4 月至 2018 年 10 月期间,这些患者在澳大利亚的一家普通诊所接受了治疗,随访期从 18 个月到 4 年不等。起初,这些孩子及其家人的症状都很难缓解,但最终都有所改善。在最后一次复查时,4 名儿童的皮肤状况明显改善,另外 4 名儿童的症状与他们之前的特应性皮炎一致。需要对长期局部皮质类固醇的使用及其停用,包括局部皮质类固醇戒断,特别是在儿科人群中进行更多的研究。

相似文献

1
Topical Steroid Withdrawal: A Case Series of 10 Children.局部皮质类固醇停药:10 例儿童病例系列。
Acta Derm Venereol. 2019 May 1;99(6):551-556. doi: 10.2340/00015555-3144.
2
A Qualitative Study Exploring the Views and Experiences of Adults Who Decided to Cease Long-term Topical Steroid Use.一项定性研究:探索决定停止长期使用外用类固醇的成年人的观点和经历。
Dermatitis. 2021;32(6):e131-e133. doi: 10.1097/DER.0000000000000720.
3
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.特应性皮炎和其他皮肤病患者局部皮质类固醇停药(“皮质类固醇成瘾”)的系统评价。
J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2. doi: 10.1016/j.jaad.2014.11.024. Epub 2015 Jan 13.
4
Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.长期局部使用皮质类固醇后的停药效应。
Dermatitis. 2018 Jul/Aug;29(4):213-218. doi: 10.1097/DER.0000000000000387.
5
Erythema, pruritus, and diffuse peeling of skin during dupilumab therapy for atopic dermatitis in three adults.三名成人在接受度普利尤单抗治疗特应性皮炎期间出现皮肤红斑、瘙痒和弥漫性脱皮。
Int J Dermatol. 2019 Jan;58(1):e14-e15. doi: 10.1111/ijd.14296. Epub 2018 Nov 2.
6
Difficulties in treating steroid withdrawal: intermittent ACTH and low dose systemic cyclosporin used to treat a senile erythroderma patient.类固醇戒断治疗中的困难:使用间歇性促肾上腺皮质激素和低剂量全身性环孢素治疗一名老年红皮病患者。
J Dermatol. 2000 Jan;27(1):44-8. doi: 10.1111/j.1346-8138.2000.tb02117.x.
7
Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.吡美莫司:新制剂。仿制药:风险太多,对特应性皮炎益处不足。
Prescrire Int. 2004 Dec;13(74):209-12.
8
Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.外用他克莫司和外用糖皮质激素序贯应用治疗儿童特应性皮炎的疗效:一项开放标签的试点研究。
J Am Acad Dermatol. 2009 Feb;60(2):212-7. doi: 10.1016/j.jaad.2008.09.034. Epub 2008 Nov 22.
9
[Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].[外用他克莫司和吡美莫司治疗儿童特应性皮炎的安全性]
Rev Alerg Mex. 2005 Jul-Aug;52(4):171-6.
10
Topical corticosteroids for skin disorders in infants and children.用于婴幼儿皮肤疾病的外用皮质类固醇激素。
Drugs. 1988;36 Suppl 5:34-7. doi: 10.2165/00003495-198800365-00007.

引用本文的文献

1
Reviewing the Evidence Base for Topical Steroid Withdrawal Syndrome in the Research Literature and Social Media Platforms: An Evidence Gap Map.回顾研究文献和社交媒体平台中局部类固醇戒断综合征的证据基础:证据缺口图。
J Med Internet Res. 2024 Dec 6;26:e57687. doi: 10.2196/57687.
2
Pediatric Topical Steroid Withdrawal Syndrome: What Is Known, What Is Unknown.儿童外用类固醇戒断综合征:已知与未知
Pediatr Dermatol. 2025 Mar-Apr;42(2):311-317. doi: 10.1111/pde.15799. Epub 2024 Nov 4.
3
Diagnosis of a recurred lesion in dermatophytosis patients after 2 weeks of antifungal therapy: A prospective observational study.
抗真菌治疗2周后皮肤癣菌病患者复发病变的诊断:一项前瞻性观察研究。
J Family Med Prim Care. 2024 Feb;13(2):465-470. doi: 10.4103/jfmpc.jfmpc_672_23. Epub 2024 Mar 6.
4
Topical steroids or emollients: does order matter?局部用皮质类固醇或保湿剂:顺序重要吗?
Arch Dermatol Res. 2024 Mar 15;316(4):104. doi: 10.1007/s00403-024-02837-0.
5
Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.类固醇恐惧症:有依据吗?局部用皮质类固醇安全性、成瘾和戒断的综述。
Clin Drug Investig. 2021 Oct;41(10):835-842. doi: 10.1007/s40261-021-01072-z. Epub 2021 Aug 18.